03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The New York State Senate and Assembly have passed two bills amending the New York Labor Law (NYLL) ...
Read More >
On November 13, 2019, the United States Court of Appeals for the Sixth Circuit issued a recommended ...
Read More >
Owner Fired Employee Who Rebuffed His Advances and Complained, Federal Agency Charges - PHOENIX, A...
Read More >
On August 28, 2019, the amendment to Transitory XI of the social security contribution towards Disab...
Read More >
In a market with soaring multiples, private equity buyers are increasingly on the hunt to mitigate h...
Read More >
Please join us for BakerHostetler's “Labor Relations and Employment: The Only Constant Is Change” ...
Read More >